Sonoma Pharmaceuticals Forum: Community User: Moma

Vielleicht finden sie noch mehr

We are working with our Audit Committee and the Company’s independent auditors to determine the full impact of these potential adjustments on the financial statements for the quarter ended June 30, 2020. However, until the review is complete and a final determination is made, we cannot provide assurance regarding the complete impact of any adjustments on the financial statements for the affected periods, and we cannot provide assurance that the adjustments identified above are representative of the adjustments that will be required when the review is complete. Furthermore, we cannot provide assurance that the review will not identify further adjustments that may be required.

Ich hab erstmal verkauft. Das macht auf mich keinen professionellen Eindruck, wenn man einen Konzernabschluss nicht richtig hinbekommt. Jetzt müssen sie erstmal den korrigieren und anschließend wohl erst Q3 Zahlen

Oh man , wie kann so etwas überhaupt passieren ?🤦‍♂️

Break even point also noch etwas weiter entfernt, wenn ich das richtig verstanden habe, bis morgen leute

Soviel? : Additionally, the changes resulted in a decrease of basic and diluted net income (loss) per common share of $0.41.

Sieht aber auch nicht gut aus! Kann das jemand bitte kommentierrn morgen

Hab gerade geschaut, das ist nicht so dramatisch, wenn ich es richtig interpretiert habe

Zahlen können noch dauern

On November 16, 2020, we requested an extension to file our quarterly report for the quarter ended September 30, 2020 in accordance with Rule 12b-25 under the Securities Exchange Act of 1934, as amended. However, there can be no assurance that we will be able to file such report within the time period prescribed by Rule 12b-25.

Wie viel

Ohje, Fehler bei Q2. Umsätze waren zu hoch

18.11 hab ich ja geschrieben 😂 morgen wissen wir mehr

🤣

Na wenn der Algo das sagt

SNOA Earnings Date Earnings announcement* for SNOA: Nov 19, 2020 Sonoma Pharmaceuticals, Inc. is estimated to report earnings on 11/19/2020. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $-0.91.